Mar 7, 2026

Featuring perspectives from Prof Nicoletta Colombo and Dr Kathleen N Moore, including the following topics:

• Introduction (0:00)
• Promising Novel Agents and Strategies Under Investigation in Ovarian Cancer (2:35)
• Current Management of Newly Diagnosed and Relapsed/Refractory Ovarian Cancer(41:48)

CME information and...

Mar 6, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Ovarian Cancer | Faculty Presentation 2: Promising Novel Agents and Strategies Under Investigation in Ovarian Cancer — Nicoletta Colombo, MD

CME information and select...

Mar 6, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Ovarian Cancer | Faculty Presentation 1: Current Management of Newly Diagnosed and Relapsed/Refractory Ovarian Cancer — Angeles Alvarez Secord, MD, MHSc

CME information and select...

Feb 16, 2026

Featuring perspectives from Dr Terence Friedlander and Dr Rana R McKay, including the following topics:

• Introduction (0:00)
• Up-Front Treatment of Ovarian Cancer (OC) (1:13)
• Management of Platinum-Resistant OC (11:49)
• Up-Front Management of Metastatic Endometrial Cancer (32:42)
• Management of HER2-Positive...

Feb 9, 2026

Featuring an interview with Dr Kathleen N Moore, including the following topics:

• Overview of the mechanism of action and pharmacology of antibody-drug conjugates (ADCs) (0:00)
• Comparing toxicities of conventional chemotherapy and ADCs (6:26)
• Potential of ADCs as maintenance therapy for ovarian cancer (11:35)
• Treatment...